Zimmer Biomet Holdings, Inc.ZBHNYSE
Loading
Operating Cash Flow Growth TrendStable
Percentile Rank69
5Y CAGR+15.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+15.4%/yr
Long-term compound
Percentile
P69
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
3 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 23.55% |
| Q3 2025 | 10.71% |
| Q2 2025 | -1.20% |
| Q1 2025 | -24.39% |
| Q4 2024 | 27.95% |
| Q3 2024 | 7.12% |
| Q2 2024 | 62.02% |
| Q1 2024 | -61.25% |
| Q4 2023 | 74.29% |
| Q3 2023 | -2.96% |
| Q2 2023 | 13.06% |
| Q1 2023 | 26.00% |
| Q4 2022 | -45.83% |
| Q3 2022 | 27.89% |
| Q2 2022 | 48.61% |
| Q1 2022 | -35.14% |
| Q4 2021 | -15.56% |
| Q3 2021 | -4.58% |
| Q2 2021 | 84.14% |
| Q1 2021 | -42.01% |
| Q4 2020 | 11.49% |
| Q3 2020 | 822.16% |
| Q2 2020 | -111.71% |
| Q1 2020 | 6.52% |
| Q4 2019 | -26.75% |
| Q3 2019 | 91.99% |
| Q2 2019 | 6.14% |
| Q1 2019 | -25.27% |
| Q4 2018 | -21.61% |
| Q3 2018 | 23.09% |
| Q2 2018 | -19.82% |
| Q1 2018 | 21.74% |
| Q4 2017 | -13.07% |
| Q3 2017 | 5.22% |
| Q2 2017 | 59.95% |
| Q1 2017 | -56.09% |
| Q4 2016 | 77.88% |
| Q3 2016 | -8.94% |
| Q2 2016 | 46.00% |
| Q1 2016 | -31.49% |